Fujirebio Europe

Foundation date

18/07/1985

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Fujirebio is a global leader in the field of high quality in vitro diagnostics (IVD) testing. It has more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products.Fujirebio has a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states.

Upcoming events

Latest news

  • Scientists discover viral trapdoor blocking HIV and herpes

    1 day ago

  • UZ Leuven and KU Leuven invest 14 million euro in new cell and gene therapy facility

    Tuesday October 8th 2024

  • Galapagos welcomes Oleg Nodelman to its Board of Directors to support strategic growth

    Monday October 7th 2024